Business · Companies · 6 hrs ago
Avicanna Moves Its US Listing to OTCQB
Avicanna announced that its US listing is moving to OTCQB, effective October 16, 2026.
The company is an international biopharmaceutical business focused on plant-derived cannabinoid products for medical and pharmaceutical markets.
It says it develops, manufactures and sells these products, and has brought more than 50 finished products to market.
Avicanna also has listings in Canada under TSX ticker AVCN and in Germany under ticker 0NN.
The change affects where its US listing is held, but no reason for the move was given.
The transition took effect on October 16, 2026; no further steps or plans were described.
Avicanna said it would transition its US listing to OTCQB effective October 16, 2026.
The company is a biopharmaceutical business focused on plant-derived cannabinoid-based products.
Avicanna is listed on the Toronto Stock Exchange as TSX: AVCN.
Its other listed symbols in the announcement are OTCQB: AVCNF and FSE: 0NN.
The announcement was distributed by GlobeNewswire and carried by the Financial Post.
- Who
- Avicanna Inc., a biopharmaceutical company.
- What
- It announced that its US listing would transition to OTCQB.
- When
- Effective October 16, 2026.
- Where
- The United States.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Effective date
- October 16, 2026
- US listing venue
- OTCQB
- US trading symbol
- OTCQB: AVCNF
- Toronto listing symbol
- TSX: AVCN
- Frankfurt listing symbol
- FSE: 0NN
What people are saying
in the US, the Company will transition to OTCQB effective October 16, 2026.